Observational, real-world study of INFLECTRA in patients with inflammatory bowel disease (IBD) in the United States and Canada (ONWARD)

08/02/2018
23/04/2024
EU PAS number:
EUPAS22444
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C1231006 PROTOCOL_Amendment 2_Pfizer_Inflectra_ONWARD_Study_25Jan2018 V3

English (455.7 KB - PDF) View document
Updated protocol

C1231006 AMENDMENT 3 PROTOCOL VERSION 3_09SEP2020_Redacted

First published: 22/02/2024
English (3.96 MB - PDF) View document
Study results
Study results

C1231006 NI Study Report Abstract

English (1.72 MB - PDF) View document
Study report
Study report

C1231006 NI Study Report

English (1.51 MB - PDF) View document
Other information